SUBSCRIBE
SUBSCRIBE

Brandon May

Genetown
Monte Rosa Secures $96 Million to Advance Small-Molecule Drug Discovery Platform
With help from investors, Monte Rosa expects the chemical libraries to comprise more than 10,000 structures designed for ubiquitin ligase reprogramming, a unique approach to destroy cancer-causing proteins that are not targetable by currently available therapies.
September 25, 2020
 · 
2 min read
 · 
Brandon May
This guide can help you navigate family medical le
Drug Development
Study: SARS-CoV-2 Infection During Pregnancy Does Not Increase Risk of Complications
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy does not appear to increase the risk of complications during delivery or negatively impact the health of newborns, according to a new JAMA study.
September 24, 2020
 · 
2 min read
 · 
Brandon May
Sitravatinib is showing positive results.
Drug Development
Mirati’s Sitravatinib Shows Promising Phase II Results in Urothelial Cancer Patients
San Diego-based Mirati Therapeutics, a clinical-stage biotechnology company, is currently developing sitravatinib to address unmet medical needs in cancer care.
September 20, 2020
 · 
3 min read
 · 
Brandon May
Octreotide capsules are the new hope for acromegal
Genetown
Chiasma’s Octreotide Capsules Could Be Answer to Acromegaly Treatment Burdens
Octreotide, a somatostatin analog, significantly inhibits growth hormone, one of the key drivers of acromegaly.
September 17, 2020
 · 
4 min read
 · 
Brandon May
BioCapital
UPMC Researchers Isolate Tiny Antibody That Neutralizes SARS-CoV-2 Virus
The researchers used this antibody, which is 10-times smaller than a full-sized antibody and the smallest isolated biological molecule to date, to develop a potential therapeutic and prophylactic agent against the virus termed “Ab8.”
September 16, 2020
 · 
2 min read
 · 
Brandon May
Continuous glucose monitoring system.
Business
New Artificial Pancreas Offers Hope for Children with Poorly Controlled Type 1 Diabetes
The study, led by U.S. researchers, showed that the novel system was safe and effective for managing blood glucose in children as young as 6 years old.
September 15, 2020
 · 
4 min read
 · 
Brandon May
Biotech Bay
ESCAPE Bio Snags $73 Million to Advance Neurodegenerative Clinical Development Programs
Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration.
September 15, 2020
 · 
2 min read
 · 
Brandon May
Deals
Grail Files for IPO Ahead of Launching Multi-Cancer Liquid Biopsy Screening Test
Grail, a spin out of genome sequencing firm Illumina, filed a preliminary prospectus for a $100 million initial public offering (IPO) last week with the U.S. Securities and Exchange Commission (SEC).
September 14, 2020
 · 
2 min read
 · 
Brandon May
Drug Development
Feline Antiviral Therapy Shows Promise Against SARS-CoV-2 in Human Cells
A study published in Nature Communications on August 27 shows that a feline antiviral drug was effective at inhibiting the replication of human coronaviruses in cell cultures infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
September 9, 2020
 · 
2 min read
 · 
Brandon May
Load More